Positive Interim Results of CHOICE-01 Study Evaluating Junshi Biosciences and Coherus’ Toripalimab for First Line Treatment of Non-Small Cell Lung Cancer Presented at World Conference on Lung Cancer

Brenda Snow
Authentic Patient Voice

Matt Turner
Patient Affordability

Daniel Sontupe
Market Access

Bud Bilanich
Success Coach

Joey Cohen
Medication Adherence

Amy Giles
Increasing Engagement

Frank Burrell
Scientific Storytelling

Matthew Durham
Omnidynamic Marketing

David Linetsky
Point-of-Care Marketing

Stacey Gandler
Brand Nourishment

Paul Theisen
Patient Acquisition

Pat Purcell
Meeting Engagement

Suma Ramadas, PhD
Medical Affairs

Liz Kane
Impactful Strategy